Monthly Prescribing Reference

Avonex Pen and New Dose Titration Regimen Available

AVONEX PEN (interferon beta-1a) 30mcg/0.5mL solution for injection by Biogen Idec The Avonex Pen (interferon beta-1a 30mcg/0.5mL solution for injection), the first IM autoinjector for chronic use in ...
FiercePharma

Biogen Idec Receives Approval in the European Union for AVONEX® PEN™

European Commission approves the first single-use intramuscular autoinjector designed to improve convenience of once-weekly AVONEX (interferon beta-1a) administration “At Biogen Idec, our commitment ...
The Business Journals

Biogen Avonex Pen approved in EU

Biogen Idec has won European regulatory approval for a new delivery method for its blockbuster multiple sclerosis (MS) drug, Avonex, called the Avonex Pen. This is the first approval for the Avonex ...
Monthly Prescribing Reference

FDA Approves Avonex Pen and Dose Titration Regimen

AVONEX PEN (interferon beta-1a) 30mcg/0.5mL solution for injection by Biogen Idec Biogen Idec has received approval from the FDA for Avonex Pen (30mcg/0.5mL solution for injection) for patients ...
FiercePharma

Biogen Idec Receives Positive Opinion from the CHMP and Authorisation from Health Canada on AVONEX PEN

-- First single-use intramuscular autoinjector designed to improve convenience of once-weekly AVONEX recommended for approval in the European Union and authorised in Canada -- AVONEX PEN is designed ...
Business Wire

AVONEX PEN Now Available for Multiple Sclerosis Patients in Canada

MISSISSAUGA, Ontario--(BUSINESS WIRE)--Biogen Idec Canada Inc today announced AVONEX ® PEN ™ is now available for patients with relapsing multiple sclerosis (MS) and patients with a single ...
GEN

EU Approves Biogen Idec’s Avonex Intramuscular Autoinjector Product for MS

Study showed 94% of patients preferred new device over existing Avonex prefilled syringe. The European regulatory authorities approved Biogen Idec’s single-use intramuscular autoinjector, Avonex PEN, ...
MM&M

Biogen Idec sees revenue surge on MS drug sales

Biogen Idec saw revenue rise 18% in the second quarter to $1.4 billion amid strong sales of Avonex, with a host of promising late-stage pipeline products waiting in the wings. Revenues from the firm’s ...
FierceBiotech

FDA Approves AVONEX® PEN™ and Dose Titration Regimen

Dosing Enhancements May Improve Treatment Experience for Patients Receiving AVONEX® (interferon beta-1a) for Multiple Sclerosis WESTON, Mass.--(BUSINESS WIRE)--Today Biogen Idec (NASDAQ: BIIB) ...
Business Wire

CORRECTING and REPLACING Biogen Idec Receives Approval in the European Union for AVONEX ® PEN

ZUG, Switzerland--(BUSINESS WIRE)--Third paragraph, first sentence should read: ....AVONEX 30mcg/0.5ml... (sted ...AVONEX 30mcg/50ml...) The corrected release reads ...
Drug Store News

FDA approves Biogen Idec's Avonex Pen, dose titration regimen

WESTON, Mass. — The Food and Drug Administration has approved two separate dosing innovations for multiple sclerosis patients that are being treated with a Biogen Idec drug. Biogen Idec said the FDA ...